NCT07185074View on ClinicalTrials.gov

Effect of Lidocaine Aerosol Plus Low-dose Cisatracurium vs Conventional-dose Cisatracurium on Intubation Conditions in ERCP - A Randomized Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

January 17, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Intubation, Intratracheal
Interventions
DRUG

Cisatracurium 0.05 mg/kg IV

Single bolus at induction; used in the experimental arm. Approximate potency reference: 0.05 mg/kg is about 1 x ED95.

DRUG

Cisatracurium 0.15 mg/kg IV

Single bolus at induction; used in the active comparator arm. Approximate potency reference: 0.15 mg/kg is about 3 x ED95.

DRUG

Lidocaine aerosol 2.4% topical

Three sprays to the glottic area immediately before intubation; used only in the experimental arm.

Trial Locations (1)

201203

RECRUITING

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai

All Listed Sponsors
lead

Jiangang Song

OTHER